Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

समान संसाधन

• PD-1 and PD-L1 antibodies for melanoma
  द्वारा: Tsai, Katy K, और अन्य
  प्रकाशित: (2015)
• Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
  द्वारा: Daud, Adil I., और अन्य
  प्रकाशित: (2016)
• Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
  द्वारा: Tumeh, Paul C., और अन्य
  प्रकाशित: (2017)
• Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
  द्वारा: Hamid, Omid, और अन्य
  प्रकाशित: (2013)
• Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy
  द्वारा: Loo, Kimberly, और अन्य
  प्रकाशित: (2017)